- Hypertrophic Cardiomyopathy (HCM)
- Eyecare
- Urothelial Carcinoma
- Hemophilia
- Heart Failure
- Vaccines
- Neonatal Care
- NSCLC
- Type II Inflammation
- Substance Use Disorder
- Gene Therapy
- Lung Cancer
- Spinal Muscular Atrophy
- HIV
- Post-Acute Care
- Liver Disease
- Asthma
- Atrial Fibrillation
- COVID-19
- Cardiovascular Diseases
- Prescription Digital Therapeutics
- Reproductive Health
- The Improving Patient Access Podcast
- Blood Cancer
- Ulcerative Colitis
- Respiratory Conditions
- Multiple Sclerosis
- Digital Health
- Population Health
- Sleep Disorders
- Biosimilars
- Plaque Psoriasis
- Leukemia and Lymphoma
- Oncology
- Pediatrics
- Urology
- Obstetrics-Gynecology & Women's Health
- Opioids
- Solid Tumors
- Autoimmune Diseases
- Dermatology
- Diabetes
- Mental Health
Remote Care Technology Top Pick for ’23 Impact | Managed Healthcare Executive® State of the Industry Survey
In the political and policy arena, respondents see implementation of the Inflation Recovery Act as having a major effect this year.
Healthcare technology is teeming with possibilities for improving the cost and delivery of healthcare. Precision medicine, artificial intelligence, prescription digital therapeutics — they are all being talked about as powerful waves that will shape the future contours of U.S. healthcare.
But as far as having an effect this year, remote are technologies was the top pick among the respondents to the Managed Healthcare Executive® annual State of the Industry survey. A solid majority — 56% — of the approximately 450 respondents to the survey indicated that remote care technology would be among the healthcare technology developments to have the biggest effect on the cost and delivery of healthcare in 2023.
One-third (33%) of the respondents picked interoperability. A similar proportion (32%) picked prescription digital therapeutics. The respondents were instructed to pick more than one of the choices, which also included gene therapy,precision medicine and artificial intelligence
In the policy and political arena, implementation of the healthcare provisions of the Inflation Recovery Act was the top pick for making a splash this year: 54% of the respondents picked it in response a question which policy and political developments will have the biggest effect this year. Perhaps the most important provision of the law is the one that empowers CMS to negotiate drug prices. According to a timeline that CMS issued last week, CMS will publish a list of the first 10 drugs for which it will negotiate a price on Sept. 1, 2023, but it won’t be until 2026 that the negotiated prices will go into effect.
A little more than one-third (35%) respondents picked the end of the COVID-19 public health emergency as having a large effect this year and less than one-third (31%) picked the end of continuous Medicaid enrollment.
The survey was conducted online in November and early December. Medical Economics® assisted with its distribution,
Bridging the Diversity Gap in Rare Disease Clinical Trials with Harsha Rajasimha of IndoUSrare
November 8th 2023Briana Contreras, an editor with Managed Healthcare Executive, spoke with Harsha Rajasimha, MD, founder and executive chairman of IndoUSrare, in this month's episode of Tuning in to the C-Suite podcast. The conversation was about how the disparity in diversity and ethnicity in rare disease clinical trials in the U.S. has led to gaps in understanding diseases and conditions, jeopardizing universal health, and increasing the economic burden of healthcare.
Listen
Study Raises Concerns Over Insurance Barriers to HIV Prevention Medications
November 29th 2023Despite its efficacy, PrEP remains underutilized compared to the need for it. High costs are among the barriers to PrEP use, along with limited knowledge among clinicians, lack of health insurance, stigma, and underestimation of personal HIV risk.
Read More
Managing Editor of Managed Healthcare Executive, Peter Wehrwein, had a discussion with William Shrank, M.D., a venture partner with Andreessen Horowitz, a venture capital firm in Menlo Park, California, about how artificial intelligence's role is improving healthcare, where we are today with value-based care and the ongoing efforts of reducing waste in the healthcare space for this episode of the "What's on Your Mind" podcast series.
Listen
